Immunai, which uses AI to analyze the human immune system, raises $60M Series A led by Schusterman Foundation and others (Kyle Wiggers/VentureBeat)

Immunai, which uses AI to analyze the human immune system, raises $60M Series A led by Schusterman Foundation and others (Kyle Wiggers/VentureBeat)

Kyle Wiggers / VentureBeat:Immunai, which uses AI to analyze the human immune system, raises $60M Series A led by Schusterman Foundation and othersImmunai, a startup developing an AI platform to analyze the human immune system, today announced that it raised $60 million. The company says it will use the funds
Click here to read full news..

Share

You may also like...

Leave a Reply

Your email address will not be published. Required fields are marked *